Back

Financial Year 2024 First Half Results and USA Expansion Updates

3rd September 2024

Tags

Events News Videos Cyclomedica Cyclopharm Technegas Presentations

A video presentation from September 3rd, 2024 of Cyclopharm’s 2024 Half-Year Results & USA Expansion Update

In this video, CEO & Managing Director James McBrayer and CFO Jason Smith present Cyclopharm’s first-half 2024 results and exciting USA expansion updates. Key highlights include a surge in Technegas® demand following CMS reimbursement approval, the addition of 11 contracted sites in the US, and stable global revenue from sales across 66 countries. They also discuss strong third-party consumable sales, a successful $20 million capital raise, and the company’s ‘Beyond PE’ strategy to expand Technegas® applications. With a solid cash position of $27.56 million, Cyclopharm is well-positioned for continued growth.

Watch to learn more about our strategic roadmap.

Related content

Watch this video: enter your details for immediate access

To access the video on this page, we kindly ask you to provide your name and contact details. Accurate information is required for access, as this helps us ensure you receive the most relevant updates and resources. Thank you for your cooperation and interest!

Which of the following groups do you best fit?
Which news would you like to receive?
Do you currently hold shares in this company?

* Required fields.

Subscribe to receive Cyclomedica’s company announcements through our email alerts service by simply responding to the three questions above. Your privacy is important to us. If you no longer want to receive email alerts, use the unsubscribe link. If you are a shareholder and wish to change your details or check your holdings, then use the share registry information on the contact us page.

Please wait...
Thank you.
Oops! Something went wrong. Please try again.
Next page
Investors